Dr. Tuhina Neogi, MD
Not yet claimedRheumatologist · Physician (MD)
Boston, MA
Dr. Tuhina Neogi is a rheumatologist at Boston Medical Center. Her work focuses on gout and osteoarthritis.
About Dr. Tuhina Neogi, MD
Updated Sep 20, 2026 · next review Dec 19, 2026Dr. Tuhina Neogi is a rheumatologist and epidemiologist in Boston. She is Chief of Rheumatology at Boston Medical Center and Section Chief of Rheumatology at Boston University, where she is also a Professor of Medicine and a Professor of Epidemiology at the School of Public Health.
She earned her MD at the University of Toronto and did her internal medicine residency and rheumatology fellowship there, then completed a PhD in epidemiology at Boston University School of Public Health. Her hospital profile describes her as a board-certified rheumatologist. She sees patients at Boston Medical Center.
Her research and clinical focus is gout and osteoarthritis. Her university profile reports more than 300 peer-reviewed publications and continuous NIH or foundation research funding since 2003. She was a co-author of the 2020 American College of Rheumatology guideline for managing gout, chairs the ACR Committee on Quality of Care, and is a past chair of the FDA Arthritis Advisory Committee. In 2025 the ACR gave her its Excellence in Investigative Mentoring Award.
CMS Open Payments records list $130,791.27 in payments from industry to her across 58 records for 2021-2025, with the largest amounts from Pfizer, Regeneron, GlaxoSmithKline, Novartis and EMD Serono. Payments from drug and device companies to physicians are common and legal, and are often tied to research or speaking work.
- Chief of Rheumatology
- She is Chief of Rheumatology at Boston Medical Center and Section Chief of Rheumatology at Boston University. bmc.org
- Gout guideline co-author
- She co-authored the 2020 American College of Rheumatology Guideline for the Management of Gout. bumc.bu.edu
- Trained as an epidemiologist
- Along with her MD from the University of Toronto, she holds a PhD in epidemiology from Boston University School of Public Health and is a Professor of Epidemiology there. bu.edu
- Endowed professorship
- She was named the Alan S. Cohen, MD Professor of Rheumatology at Boston University in 2021. bumc.bu.edu
- Quality of care leadership
- She chairs the American College of Rheumatology Committee on Quality of Care and has worked on classification criteria, outcome measures and treatment guidelines for rheumatoid arthritis, gout and other rheumatic diseases. the-rheumatologist.org
- Past FDA advisory committee chair
- She is a past chair of the U.S. FDA Arthritis Advisory Committee. the-rheumatologist.org
- 2025 mentoring award
- The American College of Rheumatology named her a recipient of its 2025 Excellence in Investigative Mentoring Award. rheumatology.org
- Active research funding
- Her university profile lists active NIH grants including a P30 clinical research center, the MOST 4 osteoarthritis study, and the TRUST gout trial. profiles.bu.edu
- Framingham Heart Study
- She is an investigator with the Framingham Heart Study. framinghamheartstudy.org
- Society board service
- She has served on the boards of the Osteoarthritis Research Society International (OARSI) and the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN). events.utsouthwestern.edu
Worth knowing
- CMS Open Payments lists $130,791.27 in industry payments to her across 58 records for 2021-2025, with the largest totals from Pfizer, Regeneron, GlaxoSmithKline, Novartis and EMD Serono. Such payments are common and legal, and can include research support, consulting or speaking. openpaymentsdata.cms.gov
- Her board certification is stated on her hospital profile but was not independently confirmed with the certifying board; one health-plan directory lists her certification data as 'Not Provided.' phppd.providence.org
Industry payments (CMS Open Payments)
Open the CMS recordFederal law requires drug and device companies to report what they pay clinicians: meals, travel, speaking, consulting, and research. Payments are common and legal; the point is that you can see them.
2021 to 2025
$130,791
58 payments
| 2021 | $45,454 |
| 2022 | $53,442 |
| 2023 | $13,530 |
| 2024 | $9,900 |
| 2025 | $8,465 |
Top payers
- PFIZER INC.$35,809
- Regeneron Pharmaceuticals, Inc.$15,132
- GlaxoSmithKline, LLC.$12,879
- Novartis Pharmaceuticals Corporation$9,248
- EMD Serono, Inc.$8,797
Payment types
- Consulting Fee$87,968
- Honoraria$40,230
- Travel and Lodging$1,870
- Food and Beverage$620
- Education$104
A word of caution about these numbers
A payment does not mean your doctor is compromised or acting unethically. Most of these entries are drug samples left for patients, or lunch brought in for the office staff, and the amounts are usually small. Research funding and speaking at medical meetings are also normal parts of a clinical career.
As a rough guide, a total under $15,000 a year is usually not a concern. Much larger sums, especially from one company whose product your doctor recommends to you, are worth asking about. You are allowed to ask.
Sources: bmc.org · profiles.bu.edu · bu.edu · x.com · linkedin.com · doximity.com · rheumnow.live · phppd.providence.org. Something wrong or out of date? Tell us and we will correct it.
Summary prepared with AI assistance from the public sources linked above, reviewed every three months. It is not a review, a rating, or an endorsement.
Practice location
Boston Medical Center
725 Albany Street
Boston, MA 02118
Open in maps